| P/E (FY) | — | Sales (TTM) | SEK 1.95B |
| Earnings (TTM) | -SEK 5.5M | ROE | −0.18% |
| Net Margin | −0.28% | ROIC | −6.48% |
| Debt / Equity | 0.45 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 15.68% |
BICO Group AB supplies hardware, laboratory automation, and software solutions across North America, Europe, Asia, and internationally, operating through Life Science Solutions and Lab Automation segments. Its bioprinting offerings include 3D bioprinters and bioinks aimed at accelerating drug discovery, while its life science range covers lab instrumentation and consumables for cell culture, imaging, sorting, and sample preparation, and the Lab Automation segment provides the hardware-agnostic Green Button Go software along with integration, consulting, and engineering services for automated lab systems. The company serves pharma, biotech, diagnostics, academia, and cosmetics customers through its own sales organizations and distributor network. Formerly known as Cellink AB, it took the BICO Group name in August 2021; it was incorporated in 2016 and is headquartered in Gothenburg, Sweden.
| Market Cap | $1.0M | Trading Days | 2393 |
| 52W High | 42.46 |
| 52W Low | 12.94 |
| % Off High | −65.90% |
| YTD | −31.24% | 1Y | −63.53% |
| 3Y | −65.69% | 5Y | −97.38% |
| Since incept. (ann.) | 0.63% |
| Ann. Volatility (1Y) | 57.61% | Ann. Volatility (3Y) | 69.31% |
| Sharpe (1Y) | −1.49 | Sharpe (3Y) | −0.25 |
| Max Drawdown (1Y) | −67.25% | Max Drawdown (3Y) | −81.38% |
| Beta (3Y, vs SPY) | 1.99 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. | $939,127 | — |
| BJDX | Bluejay Diagnostics, Inc. | $909,101 | — |
| ATXI | AVENUE THERAPEUTICS, INC. | $1.2M | — |
| VIVS | VivoSim Labs, INC. | $1.2M | — |
| LYRA | Lyra Therapeutics, Inc. | $843,069 | — |
| AEMD | AETHLON MEDICAL INC | $1.3M | — |
| HEPA | Hepion Pharmaceuticals, Inc. | $1.3M | — |
| VTAK | Catheter Precision, Inc. | $761,431 | — |
| PTIX | Protagenic Therapeutics, Inc.\new | $685,993 | — |
| BBLG | Bone Biologics Corp | $1.6M | — |
| IVF | INVO Fertility, Inc. |
| $1.6M |
| — |
| IMCC | IM Cannabis Corp. | $637,229 | — |
